Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021

The International CMV Symposium Faculty

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations

Abstract

The CMV Symposium in September 2021 was an international conference dedicated to cytomegalovirus (CMV) infection after solid organ or hematopoietic stem cell transplantation. This review provides an overview of the presentations given by the expert faculty, supplemented with educational clinical cases. Topics discussed include CMV epidemiology and diagnosis, the burden of CMV infection and disease, CMV-specific immunity and management of CMV in transplant settings. Major advances in the prevention and treatment of CMV in the past decade and increased understanding of CMV immunity have led to improved patient outcomes. In the future, management algorithms may be individualized based on the transplant recipient's immune profile, which will mark the start of a new era for patients with CMV. (Figure presented.).

Original languageEnglish
Article numbere13977
JournalTransplant Infectious Disease
Volume24
Issue number6
DOIs
StatePublished - Dec 2022

Bibliographical note

Publisher Copyright:
© 2022 The Authors. Transplant Infectious Disease published by Wiley Periodicals LLC.

Keywords

  • cellular therapy
  • cytomegalovirus immunoglobulin (CMVIG)
  • hematopoietic stem cell transplant
  • prophylaxis
  • solid organ transplant
  • treatment
  • vaccine

Fingerprint

Dive into the research topics of 'Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021'. Together they form a unique fingerprint.

Cite this